SCHEMBL28002712

SCHEMBL28002712

Fc1cccc(C2=CNC(C=S)N2)c1

nearest known ligand 0.35

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
▸ TAAR1 Q96RJ0 3/20 0.35
▸ ESR2 Q92731 1/20 0.35
▸ IDO1 P14902 2/20 0.34
▸ NISCH Q9Y2I1 1/20 0.33
▸ PGR P06401 2/20 0.33
▸ NPC1 O15118 1/20 0.32
▸ NFKB1 P19838 1/20 0.32
▸ RAB9A P51151 1/20 0.32
▸ NFKB2 Q00653 1/20 0.32
▸ RELA Q04206 1/20 0.32
▸ SMN1; SMN2 Q16637 1/20 0.32
▸ NOTUM Q6P988 2/20 0.32
▸ NFE2L2 Q16236 1/20 0.32
▸ RXFP1 Q9HBX9 1/20 0.31
▸ APOBEC3G Q9HC16 1/20 0.31
▸ HTR7 P34969 1/20 0.31
▸ HSD17B1 P14061 1/20 0.31
▸ HSD17B2 P37059 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL28003039 0.81 KDM4E (0.36) TAAR1IDO1PGRNOTUM
SCHEMBL28079677 0.81 KDM1A (0.40) IDO1NOTUM
SCHEMBL27817087 0.80 P2RX7 (0.30) —
SCHEMBL28002692 0.77 XDH (0.38) —
SCHEMBL28003061 0.72 CYP2A6 (0.42) NISCHSMN1; SMN2
SCHEMBL28002690 0.70 LMNA (0.34) NOTUM
SCHEMBL28003002 0.70 CYP1A2 (0.30) —
SCHEMBL28831583 0.70 NISCH (0.32) NISCH
SCHEMBL28002684 0.65 DCUN1D1 (0.33) IDO1NISCHNPC1RAB9ASMN1; SMN2
SCHEMBL198702 0.64 TAAR1 (0.68) TAAR1ESR2IDO1NISCHNOTUM

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-104411709-B Can be used as imidazo [2, the 1] thiazole-3-ketone derivatives of the diagnostic agent of Alzheimer 霍夫曼-拉罗奇有限公司 2016-08-24 — — CN disclosed
CN-104411709-A Imidazo [2,1]thiazol-3-one derivatives useful as diagnostic agents for alzheimer's disease HOFFMANN LA ROCHE 2015-03-11 — — CN disclosed
Send feedback